Elekta AB (publ) (EKTAF)
USD 5.0
(0.0%)
USD 5.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 2.03 Billion SEK | 5.65% |
| 2023 | 1.93 Billion SEK | 25.57% |
| 2022 | 1.53 Billion SEK | -18.85% |
| 2021 | 1.89 Billion SEK | -3.07% |
| 2020 | 1.95 Billion SEK | 11.21% |
| 2019 | 1.75 Billion SEK | -2.61% |
| 2018 | 1.8 Billion SEK | 37.08% |
| 2017 | 1.31 Billion SEK | 10.96% |
| 2016 | 1.18 Billion SEK | 26.57% |
| 2015 | 937 Million SEK | -45.74% |
| 2014 | 1.72 Billion SEK | -14.17% |
| 2013 | 2.01 Billion SEK | 8.82% |
| 2012 | 1.84 Billion SEK | 23.1% |
| 2011 | 1.5 Billion SEK | 21.92% |
| 2010 | 1.23 Billion SEK | 48.43% |
| 2009 | 830 Million SEK | 27.69% |
| 2008 | 650 Million SEK | 27.7% |
| 2007 | 509 Million SEK | 12.36% |
| 2006 | 453 Million SEK | 24.45% |
| 2005 | 364 Million SEK | 18.95% |
| 2004 | 306 Million SEK | -5.26% |
| 2003 | 323 Million SEK | 56.04% |
| 2002 | 207 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | 698 Million SEK | 9.58% |
| 2024 Q1 | 470 Million SEK | -47.89% |
| 2024 FY | 2.36 Billion SEK | 22.38% |
| 2024 Q2 | 620 Million SEK | 31.91% |
| 2024 Q3 | 637 Million SEK | 2.74% |
| 2023 Q2 | 357 Million SEK | 84.97% |
| 2023 Q3 | 557 Million SEK | 56.02% |
| 2023 Q4 | 902 Million SEK | 61.94% |
| 2023 FY | 1.93 Billion SEK | 25.57% |
| 2023 Q1 | 193 Million SEK | -64.91% |
| 2022 Q3 | 339 Million SEK | -33.92% |
| 2022 Q4 | 550 Million SEK | 62.24% |
| 2022 FY | 1.53 Billion SEK | -18.85% |
| 2022 Q1 | 134 Million SEK | -70.93% |
| 2022 Q2 | 513 Million SEK | 282.84% |
| 2021 FY | 1.89 Billion SEK | -3.07% |
| 2021 Q4 | 461 Million SEK | -1.5% |
| 2021 Q1 | 335 Million SEK | -49.09% |
| 2021 Q2 | 559 Million SEK | 66.87% |
| 2021 Q3 | 468 Million SEK | -16.28% |
| 2020 Q2 | 321 Million SEK | 36.02% |
| 2020 Q3 | 443 Million SEK | 38.01% |
| 2020 Q4 | 658 Million SEK | 48.53% |
| 2020 FY | 1.95 Billion SEK | 11.21% |
| 2020 Q1 | 236 Million SEK | -68.74% |
| 2019 Q4 | 755 Million SEK | 142.77% |
| 2019 Q3 | 311 Million SEK | -20.87% |
| 2019 Q1 | 238 Million SEK | -68.35% |
| 2019 Q2 | 393 Million SEK | 65.13% |
| 2019 FY | 1.75 Billion SEK | -2.61% |
| 2018 Q2 | 440 Million SEK | 56.58% |
| 2018 Q4 | 752 Million SEK | 83.86% |
| 2018 FY | 1.8 Billion SEK | 37.08% |
| 2018 Q1 | 281 Million SEK | 238.55% |
| 2018 Q3 | 409 Million SEK | -7.05% |
| 2017 Q3 | 288 Million SEK | 12.06% |
| 2017 FY | 1.31 Billion SEK | 10.96% |
| 2017 Q1 | 55 Million SEK | 243.75% |
| 2017 Q4 | 83 Million SEK | -71.18% |
| 2017 Q2 | 257 Million SEK | 367.27% |
| 2016 FY | 1.18 Billion SEK | 26.57% |
| 2016 Q4 | 16 Million SEK | -89.19% |
| 2016 Q1 | -63 Million SEK | -112.68% |
| 2016 Q3 | 148 Million SEK | -54.04% |
| 2016 Q2 | 322 Million SEK | 611.11% |
| 2015 FY | 937 Million SEK | -45.74% |
| 2015 Q3 | 250 Million SEK | -19.35% |
| 2015 Q4 | 497 Million SEK | 98.8% |
| 2015 Q1 | -120 Million SEK | -111.36% |
| 2015 Q2 | 310 Million SEK | 358.33% |
| 2014 Q1 | 80 Million SEK | -92.98% |
| 2014 FY | 1.72 Billion SEK | -14.17% |
| 2014 Q4 | 1.05 Billion SEK | 306.15% |
| 2014 Q2 | 331 Million SEK | 313.75% |
| 2014 Q3 | 260 Million SEK | -21.45% |
| 2013 Q3 | 393 Million SEK | -4.15% |
| 2013 Q2 | 410 Million SEK | 485.71% |
| 2013 FY | 2.01 Billion SEK | 8.82% |
| 2013 Q1 | 70 Million SEK | -90.97% |
| 2013 Q4 | 1.13 Billion SEK | 189.82% |
| 2012 Q4 | 775 Million SEK | 24.4% |
| 2012 Q1 | 92 Million SEK | -87.75% |
| 2012 FY | 1.84 Billion SEK | 23.1% |
| 2012 Q2 | 385 Million SEK | 318.48% |
| 2012 Q3 | 623 Million SEK | 61.82% |
| 2011 Q2 | 302 Million SEK | 97.39% |
| 2011 Q4 | 751 Million SEK | 153.72% |
| 2011 Q3 | 296 Million SEK | -1.99% |
| 2011 Q1 | 153 Million SEK | -77.47% |
| 2011 FY | 1.5 Billion SEK | 21.92% |
| 2010 Q1 | 89 Million SEK | 0.0% |
| 2010 Q3 | 232 Million SEK | 0.0% |
| 2010 Q4 | 679 Million SEK | 192.67% |
| 2010 Q2 | 232 Million SEK | 160.67% |
| 2010 FY | 1.23 Billion SEK | 48.43% |
| 2009 FY | 830 Million SEK | 27.69% |
| 2008 FY | 650 Million SEK | 27.7% |
| 2007 FY | 509 Million SEK | 12.36% |
| 2006 FY | 453 Million SEK | 24.45% |
| 2005 FY | 364 Million SEK | 18.95% |
| 2004 FY | 306 Million SEK | -5.26% |
| 2003 FY | 323 Million SEK | 56.04% |
| 2002 FY | 207 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -175038.719% |
| Ansell Limited | 129.3 Million USD | -1476.953% |
| Ansell Limited | 129.3 Million USD | -1476.953% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -6448.229% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 127880.831% |
| Psykey, Inc. | -797.5 Thousand USD | 255772.699% |
| ConvaTec Group Plc | 262.7 Million USD | -676.171% |
| ConvaTec Group Plc | 262.7 Million USD | -676.171% |
| Encision Inc. | -640.78 Thousand USD | 318304.447% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 1437939.363% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 1854916.702% |
| Innovative MedTech Inc. | -4.27 Million USD | 47806.218% |
| LifePoint, Inc. | -7.49 Million USD | 27303.976% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 31566.049% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -617778.788% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 1659307.421% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 436456.944% |
| SmileDirectClub, Inc. | -241.15 Million USD | 945.511% |
| Sector 10, Inc. | -39.84 Thousand USD | 5117558.087% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | -537.971% |
| SheerVision, Inc. | 155.72 Thousand USD | -1309251.04% |
| United Health Products, Inc. | -2.42 Million USD | 84129.146% |
| Vasamed, Inc. | 4.74 Million USD | -42895.996% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 88978.582% |
| Yubo International Biotech Limited | -1.2 Million USD | 169280.309% |